Published online before print February 3, 2003, doi: 10.1161/01.CIR.0000057794.29667.08
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:807.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
Inhibitory Effect of Natriuretic Peptides on Aldosterone Synthase Gene Expression in Cultured Neonatal Rat Cardiocytes
From the Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto (T.I., M. Yoshimura, S.N., M.N., Y. Shimasaki, E.H., M. Yamamuro, H.O.); Kumamoto Aging Research Institute, Kumamoto (Y.M., H.Y.); The Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto University Graduate School of Medicine, Kyoto (M.H., K.N.); First Department of Internal Medicine, Nara Medical University, Nara (Y. Saito); and Division of Integrative Cell Biology, Department of Embryogenesis Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto (H.K.), Japan.
Correspondence to Michihiro Yoshimura, MD, Department of Cardiovascular Medicine, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. E-mail bnp{at}kumamoto-u.ac.jp
Background— Although previously thought to be synthesized solely in adrenal cortex, we have recently showed that aldosterone is also produced in and the expression of CYP11B2 mRNA was induced in the failing or hypertensive human ventricle. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormones with wide biological effects, including inhibition of renin and aldosterone production. We hypothesized that natriuretic peptides reduce the expression of CYP11B2 mRNA in the heart.
Methods and Results— To test this hypothesis, we examined whether endogenous or exogenous natriuretic peptides reduce the expression of CYP11B2 mRNA using real-time reverse transcription-polymerase chain reaction. By using HS 142–1, a functional guanylyl cyclase-A type receptor antagonist, we showed that angiotensin II (AngII) pretreated with HS 142–1 increased CYP11B2 mRNA expression (1.62±0.12-fold, HS 142–1+AngII 10-7 mol/L versus AngII 10-7 mol/L alone, P<0.0001). The treatment with exogenous (10-6 mol/L) ANP and BNP reduced CYP11B2 mRNA expression (ANP, P=0.0042; BNP, P=0.0012).
Conclusions— We showed that endogenous and exogenous natriuretic peptides reduced CYP11B2 mRNA expression in cultured neonatal rat cardiocytes. This may inhibit the cardiac renin-angiotensin-aldosterone system by suppressing the gene expression of CYP11B2 and restraining cardiac hypertrophy and fibrosis.
Key Words: angiotensin • hormones • natriuretic peptides • polymerase chain reaction
This article has been cited by other articles:
 |
|
 |
|
  S. H. Lee, T.-H. Yoo, B.-Y. Nam, D. K. Kim, J. J. Li, D.-S. Jung, S.-J. Kwak, D.-R. Ryu, S. H. Han, J. E. Lee, et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1381 - F1390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, N. F. Murphy, C. Conlon, A. Patle, S. C. Donnelly, and K. McDonald Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover Eur J Heart Fail, February 1, 2009; 11(2): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Muto, N. Ueda, T. Opthof, T. Ohkusa, K. Nagata, S. Suzuki, Y. Tsuji, M. Horiba, J.-K. Lee, H. Honjo, et al. Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2710 - H2718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, C. Conlon, A. Patle, S. C. Donnelly, and K. McDonald Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction Circulation, February 20, 2007; 115(7): 888 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction J. Am. Coll. Cardiol., February 13, 2007; 49(6): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamamuro, M. Yoshimura, M. Nakayama, K. Abe, M. Shono, S. Suzuki, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al. Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium Endocrinology, March 1, 2006; 147(3): 1314 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardioprotection Cardiovasc Res, February 1, 2006; 69(2): 318 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Karram, A. Abbasi, S. Keidar, E. Golomb, I. Hochberg, J. Winaver, A. Hoffman, and Z. Abassi Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1351 - H1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Patel, M. L. Valencik, A. M. Pritchett, J. C. Burnett Jr., J. A. McDonald, and M. M. Redfield Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H777 - H784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakanishi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, Y. Nakagawa, K. Tanimoto, S. Yasuno, et al. Role of Natriuretic Peptide Receptor Guanylyl Cyclase-A in Myocardial Infarction Evaluated Using Genetically Engineered Mice Hypertension, August 1, 2005; 46(2): 441 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bubikat, L. J. De Windt, B. Zetsche, L. Fabritz, H. Sickler, D. Eckardt, A. Godecke, H. A. Baba, and M. Kuhn Local Atrial Natriuretic Peptide Signaling Prevents Hypertensive Cardiac Hypertrophy in Endothelial Nitric-oxide Synthase-deficient Mice J. Biol. Chem., June 3, 2005; 280(22): 21594 - 21599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsuneyoshi, T. Nishina, T. Nomoto, H. Kanemitsu, R. Kawakami, O. Unimonh, K. Nishimura, and M. Komeda Atrial Natriuretic Peptide Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair Circulation, September 14, 2004; 110(11_suppl_1): II-174 - II-179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, T. Ishikawa, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity in Patients with Decompensated Congestive Heart Failure J. Nucl. Med., July 1, 2004; 45(7): 1108 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Rose, A. E. Lomax, and W. R. Giles Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2454 - H2462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. White Aldosterone: Direct Effects on and Production by the Heart J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2376 - 2383. [Full Text] [PDF]
|
|